Pilot studies of a short course of pharmacological mTOR inhibition in older human volunteers report increased responses to influenza vaccines (suggesting decreased immune senescence) and a reduction in self-reported viral respiratory infections (Mannick et al., 2014, 2018). Here, MTOR is linked to influenza.